NCT07540572 2026-04-20A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid TumorsIDEAYA BiosciencesPhase 1/2 Recruiting160 enrolled
NCT03169738 2025-02-21QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 InhibitorsImmunityBio, Inc.Phase 1/2 Withdrawn